MDM2 inhibitor alrizomadlin (APG-115) promotes antitumor activity of mitogen-activated protein kinase (MAPK) inhibitors in uveal melanoma

Wang, GF; Liang, E; Min, P; Yang, DJ; Zhai, YF

CANCER RESEARCH, 2023; 83 (7):